Carbajal-Rodríguez L

Language: Spanish
References: 7
Page: 258-260
PDF size: 94.15 Kb.

Text Extraction

No abstract

REFERENCES

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children [in Japanese]. Arerugi 1967;16:178.

2. McCringle BW, Li JS, Minich LL, Colan SD, Atz AM, Takahashi M, Vetter VL, Gersony WM, Mitchell PD, Newburger JW. Coronary artery involvement in children with Kawasaki disease. Risk factors from analysis of serial normalized measurements. Circulation 2007;116:174-9.

3. Taubert KA, Rowley AH, Shulman St. Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr 1991;119:279-82.

4. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004;110:2747-71.

5. Harada K, Yamaguchi H, Kato H, et al. Indication for intravenous gammaglobulin treatment for Kawasaki disease. In: Takahashi M, Taubert K (eds) Proceedings of the Fourth International Symposium on Kawasaki Disease, Dallas, Ts. Am Heart As 1993;459-62.

6. Harada K. Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 1991;33:805-10.

7. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in Young, American Heart Association. Pediatrics 2004;114:1708-33.